ADVERSE OUTCOMES WITH USE OF HYDRALAZINE AND NITRATE COMBINATION THERAPY IN HOSPITALIZED OLDER NON-BLACK PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (HFREF)

Phillip Lam,Daniel Dooley,Essraa Bayoumi,Jonathan Segal,Cherinne Arundel,Gerasimos Filippatos,Javed Butler,Prakash Deedwania,Wen-Chih Wu,Michel White,Marc Blackman,Charity Morgan,Ioannis Kanonidis,Wilbert Aronow,Stefan Anker,Gregg Fonarow,Ali Ahmed

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2017）

引用 0|浏览10

暂无评分

摘要

Background: A combination of hydralazine and isosorbide dinitrate is recommended to self-described African American patients with HFrEF receiving optimal therapy with ACE inhibitors and beta-blockers, unless contraindicated. We examined the association of the use of both hydralazine and nitrates

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要